KR100508992B1 - 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 - Google Patents
쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 Download PDFInfo
- Publication number
- KR100508992B1 KR100508992B1 KR10-2003-0019890A KR20030019890A KR100508992B1 KR 100508992 B1 KR100508992 B1 KR 100508992B1 KR 20030019890 A KR20030019890 A KR 20030019890A KR 100508992 B1 KR100508992 B1 KR 100508992B1
- Authority
- KR
- South Korea
- Prior art keywords
- clarithromycin
- bitter taste
- coating
- water
- insoluble polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
주입 공기 온도(Inlet air temperature) | 60℃ |
생성물 온도(Product bed temperature) | 40±2℃ |
분무 속도(Feeding rate) | 5 g/min |
주입 공기 속도(Air velocity) | 5 m/sec |
분사 노즐 압력(Spray nozzle pressure) | 1.5 bar |
분사 노즐 직경(Spray nozzle diameter) | 1.2 ㎜ |
성분명 실시예 | 1 | 2 | 3 | 4 | 5 | |
클래리스로마이신 | 99 | 96 | 90 | 80 | 70 | |
수불용성코팅층 | 에틸셀룰로오스 | 1 | 4 | 10 | 20 | 30 |
메틸렌클로라이드 | 20 | 80 | 200 | 400 | 600 | |
에탄올 | 20 | 80 | 200 | 400 | 600 |
성분명 실시예 | 6 | 7 | 8 | 9 | 10 | |
클래리스로마이신 | 99 | 96 | 90 | 80 | 70 | |
수불용성코팅층 | 하이드록시프로필메틸셀룰로오스프탈레이트(HP55) | 1 | 4 | 10 | 20 | 30 |
메틸렌클로라이드 | 10 | 40 | 100 | 200 | 300 | |
에탄올 | 10 | 40 | 100 | 200 | 300 |
성분명 실시예 | 11 | 12 | 13 | 14 | 15 | |
클래리스로마이신 | 99 | 96 | 90 | 80 | 70 | |
수불용성코팅층 | 하이드록시프로필메틸셀룰로오스프탈레이트(HP50) | 1 | 4 | 10 | 20 | 30 |
메틸렌클로라이드 | 10 | 40 | 100 | 200 | 300 | |
에탄올 | 10 | 40 | 100 | 200 | 300 |
성분명 실시예 | 16 | 17 | 18 | 19 | 20 | |
클래리스로마이신 | 99 | 96 | 90 | 80 | 70 | |
수불용성코팅층 | 유드라짓 L-100 55 | 1 | 4 | 10 | 20 | 30 |
메틸렌클로라이드 | 20 | 80 | 200 | 400 | 600 | |
에탄올 | 20 | 80 | 200 | 400 | 600 |
클래리스로마이신 | 250(역가) |
직타유당 | 95(전체중량보정) |
미결정셀룰로오스 | 100 |
저치환 하이드록시프로필셀룰로오스 | 50 |
스테아린산 마그네슘 | 5 |
Total | 500 |
용출방법(Method) | 제 2법 패들법(Paddle method) |
용출액(Medium) | 0.1M 아세트산나트륨 완충액(pH 5.0) 900mL |
회전수(Rotary speed ) | 50 rpm |
용용출시간(Time) | 30 min |
제법 | 용출율(%) |
대조예1 | 98 |
실시예1 | 99 |
실시예2 | 98 |
실시예3 | 98 |
실시예4 | 78 |
실시예5 | 62 |
실시예6 | 92 |
실시예7 | 84 |
실시예8 | 61 |
실시예9 | 30 |
실시예10 | 20 |
실시예11 | 90 |
실시예12 | 77 |
실시예13 | 54 |
실시예14 | 26 |
실시예15 | 18 |
실시예16 | 70 |
실시예17 | 25 |
실시예18 | 12 |
실시예19 | 6 |
실시예20 | 6 |
제법 | 쓴 맛 정도 |
대조예1 | 5 |
실시예1 | 5 |
실시예2 | 3 |
실시예3 | 1 |
실시예4 | 1 |
실시예5 | 1 |
실시예6 | 5 |
실시예7 | 4 |
실시예8 | 4 |
실시예9 | 3 |
실시예10 | 3 |
실시예11 | 5 |
실시예12 | 4 |
실시예13 | 4 |
실시예14 | 3 |
실시예15 | 3 |
실시예16 | 5 |
실시예17 | 3 |
실시예18 | 1 |
실시예19 | 1 |
실시예20 | 1 |
Claims (4)
- 삭제
- 삭제
- 유동층 코팅기를 사용하여 에틸셀룰로오스, 하이드록시프로필메틸셀룰로오스 프탈레이트 및 유드라짓 L-100 55 중에서 선택된 1종의 수불용성 폴리머를 메틸렌클로라이드와 에탄올의 혼합용액에 용해한 코팅액으로 클래리스로마이신을 코팅하는 방법에 있어서,상기 코팅액을 수불용성 폴리머, 메틸렌클로라이드 및 에탄올을 1:20:20의 중량비로 혼합하여 상기 클래리스로마이신을 코팅하는 단계와;코팅된 클래리스로마이신 과립을 얻은 후 부형제, 붕해제, 분말결합제 및 활택제를 사용하여 정제하는 정제화 단계를 포함하고,상기에서 코팅조건은 주입공기온도 60℃, 생성물 온도 38℃ 내지 42℃, 분무 속도 5g/min, 주입 공기 속도 5m/sec, 분사 노즐 압력 1.5bar 및 분사 노즐 직경 1.2mm인 것을 특징으로 하는 쓴 맛을 개선한 클래리스로마이신 경구용 정제 조성물의 제조방법.
- 제 3항에 있어서, 부형제는 직타유당, 분말결합제는 미결정셀룰로오스를, 붕해제는 저치환 하이드록시셀룰로오스를, 활택제는 스테아린산 마그네슘을 사용하는 것을 특징으로 하는 쓴 맛을 개선한 클래리스로마이신 경구용 정제 조성물의 제조방법.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0019890A KR100508992B1 (ko) | 2003-03-31 | 2003-03-31 | 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 |
PCT/KR2003/000814 WO2004087112A1 (en) | 2003-03-31 | 2003-04-22 | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
AU2003227373A AU2003227373A1 (en) | 2003-03-31 | 2003-04-22 | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0019890A KR100508992B1 (ko) | 2003-03-31 | 2003-03-31 | 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040085256A KR20040085256A (ko) | 2004-10-08 |
KR100508992B1 true KR100508992B1 (ko) | 2005-08-17 |
Family
ID=33128925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-0019890A KR100508992B1 (ko) | 2003-03-31 | 2003-03-31 | 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100508992B1 (ko) |
AU (1) | AU2003227373A1 (ko) |
WO (1) | WO2004087112A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100676075B1 (ko) | 2005-02-17 | 2007-02-01 | 한국유나이티드제약 주식회사 | 경구투여용 클래리스로마이신 함유 펠렛 제제 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1720524A2 (en) * | 2004-02-26 | 2006-11-15 | Ranbaxy Laboratories Limited | Extended release tablets of clarithromycin |
KR101436516B1 (ko) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 |
CN101502492B (zh) * | 2009-03-13 | 2013-11-27 | 上海微丸医药开发有限公司 | 一种克拉霉素去苦味颗粒的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
US5466712A (en) * | 1994-11-04 | 1995-11-14 | American Home Products Corporation | Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones |
ATE352289T1 (de) * | 1995-05-02 | 2007-02-15 | Taisho Pharmaceutical Co Ltd | Mittel zur oralen verabreichung |
AUPO637197A0 (en) * | 1997-04-23 | 1997-05-15 | F.H. Faulding & Co. Limited | Taste-masked pharmaceutical compositions |
DE19840256A1 (de) * | 1998-09-03 | 2000-03-09 | Basf Ag | Verfahren zur Herstellung von beschichteten festen Dosierungsformen |
-
2003
- 2003-03-31 KR KR10-2003-0019890A patent/KR100508992B1/ko active IP Right Grant
- 2003-04-22 AU AU2003227373A patent/AU2003227373A1/en not_active Abandoned
- 2003-04-22 WO PCT/KR2003/000814 patent/WO2004087112A1/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100676075B1 (ko) | 2005-02-17 | 2007-02-01 | 한국유나이티드제약 주식회사 | 경구투여용 클래리스로마이신 함유 펠렛 제제 |
Also Published As
Publication number | Publication date |
---|---|
AU2003227373A1 (en) | 2004-10-25 |
KR20040085256A (ko) | 2004-10-08 |
WO2004087112A1 (en) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2675724C (en) | Oral extended-release composition | |
KR101157220B1 (ko) | 리팍시민을 포함하는 위내성 약학적 제제 | |
KR100270491B1 (ko) | 약제 송출 시스템 및 그의 제조방법 | |
JPH11508577A (ja) | 抗菌活性物質及び徐放性パントプラゾールを含有する経口医薬品 | |
US20070231368A1 (en) | Pharmaceutical formulations of 6-11 bicyclic macrolide derivative known as edp-182 and methods for preparation thereof | |
IE880545L (en) | Sustained release matrix formulations | |
US20040048814A1 (en) | Sustained release composition contraining clarithromycin | |
JP2009530367A (ja) | 調節放出性抗生組成物およびその製造方法 | |
WO2003105810A1 (en) | Pharmaceutical compositions for drugs having ph-dependentsolubility | |
US8357394B2 (en) | Compositions and methods for improved efficacy of penicillin-type antibiotics | |
KR20070007133A (ko) | 6-머캅토퓨린의 서방형 제제 | |
WO2021091188A1 (ko) | 레바미피드 또는 이의 약학적으로 허용가능한 염을 포함하는 경구투여용 서방성 약학 조성물 | |
GB2414668A (en) | Sustained release delivery system for tetracycline compounds | |
CN102579408A (zh) | 盐酸多西环素双释放制剂及其制备方法 | |
KR100508992B1 (ko) | 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법 | |
KR20090010352A (ko) | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 | |
US20110159092A1 (en) | Extended release pharmaceutical composition comprising linezolid and process for preparing the same | |
KR100676075B1 (ko) | 경구투여용 클래리스로마이신 함유 펠렛 제제 | |
KR100370870B1 (ko) | 쓴맛이은폐된록시스로마이신과립제및그의제조방법 | |
KR100630628B1 (ko) | 고미가 차폐된 클래리스로마이신 함유 시럽용 펠렛 제제 | |
US20050260263A1 (en) | Sustained release formulation for sparingly soluble main drugs | |
EP1183013A2 (en) | Melt granulation | |
US20060264386A1 (en) | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof | |
KR100509399B1 (ko) | 정제화가 용이한 탈니플루메이트 과립의 조성물 및 그제조방법 | |
KR20040011087A (ko) | 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120703 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130717 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140728 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150712 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160726 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170705 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180823 Year of fee payment: 14 |